Article (Scientific journals)
Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: insights from the 2022 EFLM Task Group on CKD survey.
Cavalier, Etienne; Makris, Konstantinos; Portakal, Oytun et al.
2023In Clinical Chemistry and Laboratory Medicine, 0 (0)
Peer Reviewed verified by ORBi
 

Files


Full Text
10.1515_cclm-2023-0987.pdf
Author postprint (2.3 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
creatinine; cystatin C; equations; glomerular filtration rate; recommendations; survey; Clinical Biochemistry; Biochemistry (medical); General Medicine
Abstract :
[en] [en] OBJECTIVES: Chronic kidney disease (CKD) is a global health issue, ranking as the third leading cause of death worldwide. CKD diagnosis and management depend on clinical laboratory tests, necessitating consistency for precise patient care. Global harmonization of CKD testing through clinical practice guidelines (CPGs) is recommended. Prior to CPG development, assessing the current CKD testing landscape is crucial. In 2022, the European Federation of Laboratory Medicine (EFLM) conducted an online survey among European laboratories associated with EFLM, evaluating CKD testing practices, including new glomerular filtration rate (GFR) estimation methods. This report summarizes the 2022 survey findings and offers recommendations for improving CKD test standardization. METHODS: An online survey was conducted in November 2022 using a questionnaire hosted on LimeSurvey sent to European laboratories affiliated with the EFLM. The survey results were recorded in Excel files and analysed. RESULTS: The results highlight significant discrepancies among countries in unit expression, methods, cystatin C use, and GFR calculation equations. Additionally, limited attention to pediatric renal biology specifics, varied proteinuria and albuminuria result expressions, and limited awareness of GFR measurement methods through iohexol clearance are noted. CONCLUSIONS: In an effort to enhance the standardization of crucial biomarkers utilized in nephrology for evaluating renal function and diagnosing kidney injuries, the EFLM Task Group on CKD suggests nine practical recommendations tailored for European laboratories. The group is confident that implementing these measures will minimize result expression discrepancies, ultimately leading to enhanced patient care.
Disciplines :
Laboratory medicine & medical technology
Urology & nephrology
Author, co-author :
Cavalier, Etienne  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Makris, Konstantinos;  Department of Clinical Biochemistry, KAT General Hospital, Athens, Greece
Portakal, Oytun;  Department of Biochemistry, Hacettepe University Medical School, Ankara, Türkiye
Nikler, Ana;  Department of Medical Laboratory Diagnostics, University Hospital "Sveti Duh", Zagreb, Croatia
Datta, Pradip;  Siemens Healthineers Diagnostics, Newark, DE, USA
Zima, Tomas;  Institute of Medical Chemistry and Laboratory Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
Delanaye, Pierre  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de néphrologie
EFLM Task Group on CKD
Language :
English
Title :
Assessing the status of European laboratories in evaluating biomarkers for chronic kidney diseases (CKD) and recommendations for improvement: insights from the 2022 EFLM Task Group on CKD survey.
Publication date :
02 October 2023
Journal title :
Clinical Chemistry and Laboratory Medicine
ISSN :
1434-6621
eISSN :
1437-4331
Publisher :
Walter de Gruyter GmbH, Germany
Volume :
0
Issue :
0
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 05 December 2023

Statistics


Number of views
11 (4 by ULiège)
Number of downloads
3 (3 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi